The Subject Expert Committee on Covid-19 has granted emergency use approval to Bharat Biotech's Covaxin for children in the 2-18 years age group.The Subject Expert Committee (SEC) on Covid-19 has granted emergency use approval to Bharat Biotech's Covaxin for children in the 2-18 years age group.Hyderabad-based Bharat Biotech